CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Fribourg, 18 September ...

Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European UnionOSAKA, ...

TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, announces ...

Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout [1] ...

Parker Moffa, Chief Operating Officer announced today the official launch of Freight Linq, a modern freight brokerage firm ...

SAN FRANCISCO, CA AND BRENTWOOD, TN / ACCESS Newswire / September 17, 2025 / Ardent Health, a leading provider of healthcare ...

Medincell (Paris:MEDCL):Data from the completed phase 3 SOLARIS trial to be presented at the 2025 Psych Congress Annual ...

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a ...

Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma ...

BUZZ BOMB™ engages three specialized fitness influencers to grow the brand influencers have hundreds of thousands of ...

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...